Breast cancer-related lymphedema: A literature review for clinical practice

International Journal of Nursing Sciences

Volumn 3, Issue 2, 2016, Pages 202-207

  Wanchai, Ausanee ^a   Armer, Jane M ^b   Stewart, Bob R ^b   Lasinski, Bonnie B ^c,d  

^a Academic Services and Research   (Thailand)

^b UNIVERSITY OF MISSOURI   (United States)

^c Lymphedema Therapy   (United States)

^d The Boris Lasinski School   (United States)

Author keywords

Breast cancer; Breast cancer related lymphedema; Lymphedema

Indexed keywords

BREAST CANCER; CLINICAL PRACTICE; COMPRESSION BANDAGE; ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY; EXERCISE; HUMAN; LYMPHANGIOGRAPHY; LYMPHEDEMA; LYMPHOSCINTIGRAPHY; MOLECULAR PATHOLOGY; RADIOLOGICAL PARAMETERS; RESEARCH; REVIEW;

EID: 84991757043     PISSN: 23520132     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijnss.2016.04.006     Document Type: Review

References (39)

1. [1] Torre, L.A., Bray, F., Siegel, R.L., Ferlay, J., Lortet-Tieulent, J., Jemal, A., Global cancer statistics, 2012. CA Cancer J Clin 65:2 (2015), 87–108.
2. [2] American Cancer Society. Breast cancer facts and figures 2015–2016. Retrieved 15th March, 2016, from http://www.cancer.org/acs/groups/content/@research/documents/document/acspc-046381.pdf.
3. [3] Heisig, S.R., Shedden-Mora, M.C., von Blanckenburg, P., Rief, W., Witzel, I., Albert, U.S., et al. What do women with breast cancer expect from their treatment? Correlates of negative treatment expectations about endocrine therapy. Psychooncology, 2016 Feb 23, 10.1002/pon.4089 [Epub ahead of print].
4. [4] Armer, J.M., Stewart, B.R., Post-breast cancer lymphedema: incidence increases from 12 to 30 to 60 months. Lymphology 43:3 (2010), 118–127.
5. [5] Gary, D.E., Lymphedema diagnosis and management. J Am Acad Nurse Pract 19:2 (2007), 72–78.
6. ®). Retrieved November 18, 2015, from http://www.cancer.gov/about-cancer/treatment/side-effects/lymphedema/lymphedema-hp-pdq#cit/section_1.10.
7. [7] Paskett, E.D., Naughton, M.J., McCoy, T.P., Case, L.D., Abbott, J.M., The epidemiology of arm and hand swelling in premenopausal breast cancer survivors. Cancer Epidemiol Biomarkers Prev 16:4 (2007), 775–782.
8. [8] Jeffs, E., Treatment of breast cancer related lymphoedema: clinical audit results. Eur J Oncol Nurs 10:1 (2006), 71–79.
9. [9] Földi, M., Földi, E., Strobenreuther, R., Kubik, S., Folddi's textbook of lymphology for physicians and lymphedema therapists. 2nd ed., 2006, Urban & Fischer, Munich.
10. [10] Ridner, S.H., Breast cancer lymphedema: pathophysiology and risk reduction guidelines. Oncol Nurs Forum 29:9 (2004), 1285–1293.
11. [11] Avraham, T., Yan, A., Zampell, J.C., Daluvoy, S.V., Haimovitz-Friedman, A., Cordeiro, A.P., et al. Radiation therapy causes loss of dermal lymphatic vessels and interferes with lymphatic function by TGF-β1-mediated tissue fibrosis. Am J Physiol Cell Physiol 299:3 (2010), C589–C605.
12. [12] Rebegea, L., Firescu, D., Dumitru, M., Anghel, R., The incidence and risk factors for occurrence of arm lymphedema after treatment of breast cancer. Chirurgia (Bucur) 110:1 (2015), 33–37.
13. [13] Armer, J.M., Research on risk assessment for secondary lymphedema following breast cancer treatment. Cancer Epidemiol Biomarkers Prev 19:11 (2010), 2715–2717.
14. [14] International Society of Lymphology, The diagnosis and treatment of peripheral lymphedema. 2009 Consensus document of the International Society of Lymphology. Lymphology 42 (2009), 51–60.
15. [15] National Lymphedema Network, The diagnosis and treatment of lymphedema. NLN position paper, 2011, 1–19.
16. [16] Lymphoedema Framework, Best practices for the management of lymphedema. International Consensus. 2006, MEP Ltd, London.
17. [17] Golshan, M., Smith, B., Prevention and management of arm lymphedema in the patient with breast cancer. J Support Oncol 4:8 (2006), 381–386.
18. [18] Oremus M, Walker K, Dayes I, Raina P. Diagnosis and treatment of secondary lymphedema. Retrieved December 3, 2015, from https://www.cms.gov/Medicare/Coverage/DeterminationProcess/downloads/id66aTA.pdf.
19. [19] Morrell, R.M., Halyard, M.Y., Schild, S.E., Ali, M.S., Gunderson, L.L., Pockaj, B.A., Breast cancer-related lymphedema. Mayo Clin Proc 80:11 (2005), 1480–1484.
20. [20] Cormier, J.N., Xing, Y., Zaniletti, I., Askew, R.L., Stewart, B.R., Armer, J., Minimal limb volume change has a significant impacton breast cancer survivors. Lymphology 42:4 (2009), 161–175.
21. [21] Clough-Gorr, K.M., Ganz, P.A., Silliman, R.A., Older breast cancer survivors: factors associated with self-reported symptoms of persistent lymphedema over 7 years of follow-up. Breast J 16:2 (2010), 147–155.
22. [22] Shigaki, C.L., Madsen, R., Wanchai, A., Stewart, B.R., Armer, J.M., Upper extremity lymphedema: presence and effect on functioning five years after breast cancer treatment. Rehabil Psychol 58:4 (2013), 342–349.
23. [23] Kwan, W., Jackson, J., Weir, L.M., Dingee, C., McGregor, G., Olivotto, I.A., Chronic arm morbidity after curative breast cancer treatment: prevalence and impact on quality of life. J Clin Oncol 20:20 (2002), 4242–4248.
24. [24] Horning, K.M., Guhde, J., Lymphedema: an under-treated problem. Medsurg Nurs 16:4 (2007), 221–227.
25. [25] Fu, M.R., Breast cancer-related lymphedema: symptoms, diagnosis, risk reduction, and management. World J Clin Oncol 5:3 (2014), 241–247.
26. [26] Armer, J.M., The problem of post-breast cancer lymphedema: impact and measurement issues. Cancer Invest 23:1 (2005), 76–83.
27. [27] Armer, J.M., Radina, M.E., Porock, D., Culbertson, S.D., Predicting breast cancer-related lymphedema using self-reported symptoms. Nurs Res 52:6 (2003), 370–379.
28. [28] Paskett, E.D., Stark, N., Lymphedema: knowledge, treatment, and impact among breast cancer survivors. Breast J 6:6 (2000), 373–378.
29. [29] Johansson, K., Holmstrom, H., Nilsson, I., Ingvar, C., Albertsson, M., Ekdahl, C., Breast cancer patients' experiences of lymphoedema. Scand J Caring Sci 17:1 (2003), 35–42.
30. [30] National Lymphedema Network. Position statement: lymphedema risk reduction practices. Retrieved November 26, 2015, from http://www.lymphnet.org/pdfDocs/nlnriskreduction.pdf.
31. [31] Harris, S.R., Hugi, M.R., Olivotto, I.A., Levine, M., Clinical practice guidelines for the care and treatment of breast cancer: 11. Lymphedema. CAMJ 164:2 (2001), 191–199.
32. [32] Loudon, L., Petrek, J., Lymphedema in women treated for breast cancer. Cancer Pract 8:2 (2000), 65–71.
33. [33] Ostby, P.L., Armer, J.M., Dale, P.S., Van Loo, M.J., Wilbanks, C.L., Stewart, B.R., Surveillance recommendations in reducing risk of and optimally managing breast cancer-related lymphedema. J Pers Med 4:3 (2014), 424–447.
34. [34] Sieggreen, M.Y., Kline, R., Current concepts in lymphedema management. Adv Skin Wound Care 17:4 (2004), 174–180.
35. [35] Radina, E., Armer, J.M., Culbertson, S.D., Dusold, J.M., Post-breast cancer lymphedema: understanding women's knowledge of their condition. Oncol Nurs Forum 31:1 (2004), 97–104.
36. [36] Ostby, P.L., Armer, J.M., Complexities of adherence and post-cancer lymphedema management. J Pers Med 5:4 (2015), 370–388.
37. [37] Bicego, D., Brown, K., Ruddick, M., Storey, D., Wong, C., Harris, S.R., Exercise for women with or at risk for breast cancer-related lymphedema. Phys Ther 86:10 (2006), 1398–1405.
38. [38] Cho, M.O., Health care seeking behavior of Korean women with lymphedema. Nurs Health Sci 6:2 (2004), 149–159.
39. [39] Fu, M.R., Breast cancer survivors' intentions of managing lymphedema. Cancer Nurs 28:6 (2005), 446–457.